3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
3
Thoracic
1
Classical hematology
1
Conditions
Neoplasms
23
Venous Thromboembolism
20
Febrile Neutropenia
20
Anemia
20
Thrombocytopenia
15
Myelodysplastic Syndromes
14
Leukemia, Myeloid, Acute
14
Lymphoma
12
Leukemia
12
Anemia, Refractory, with Excess of Blasts
10
Anemia, Aplastic
10
Colorectal Neoplasms
9
Breast Neoplasms
8
Anemia, Iron-Deficiency
8
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Anemia, Sickle Cell
7
Neutropenia
6
Multiple Myeloma
6
Ovarian Neoplasms
5
Neoplasms, Plasma Cell
5
Lymphoma, Follicular
5
Hematologic Neoplasms
5
Fanconi Anemia, Complementation Group D1
5
Hemophilia A
4
Chemotherapy-induced Thrombocytopenia
4
Stroke
3
Pulmonary Disease, Chronic Obstructive
3
Parkinson Disease
3
Osteoporosis
3
Multiple Sclerosis
3
Interventions
Meropenem
1
Levofloxacin
1
Anti-Bacterial Agents
1
Amoxicillin-Potassium Clavulanate Combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Emergencies
×
Classical hematology
×
Clear all
NCT05393505
2022-12-06
FRANCiS-NF
The University of Hong Kong
Phase 4
Unknown
344 enrolled